Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Roberto, Lorenzetti"'
Autor:
Giorgia Burrelli Scotti, Roberto Lorenzetti, Annalisa Aratari, Antonietta Lamazza, Enrico Fiori, Claudio Papi, Stefano Festa
Publikováno v:
Clinical Endoscopy, Vol 56, Iss 6, Pp 726-734 (2023)
Background/Aims Endoscopic stenting for stricturing Crohn's disease (CD) is an emerging treatment that achieves more persistent dilatation of the stricture over time than endoscopic balloon dilatation (EBD). We aimed to explore the efficacy and safet
Externí odkaz:
https://doaj.org/article/92917d4fd65141a99f09959a68878d24
Autor:
Alessandra Aiello, Andrea Coppola, Valentina Vanini, Linda Petrone, Gilda Cuzzi, Andrea Salmi, Anna Maria Gerarda Altera, Carla Tortorella, Gina Gualano, Claudio Gasperini, Palma Scolieri, Alessia Beccacece, Serena Vita, Vincenzo Bruzzese, Roberto Lorenzetti, Fabrizio Palmieri, Emanuele Nicastri, Delia Goletti
Publikováno v:
International Journal of Infectious Diseases, Vol 122, Iss , Pp 841-849 (2022)
Objectives: In this study, we aimed to characterize the SARS-CoV-2-specific T cell response detected by the QuantiFERON SARS-CoV-2 research use only assay in terms of accuracy and T cell subsets involved compared with a homemade interferon (IFN)-γ r
Externí odkaz:
https://doaj.org/article/d1d5e7a7d8694620b6fac6088c557f16
Autor:
Angelo Zullo, Giulia Fiorini, Gabrio Bassotti, Francesco Bachetti, Fabio Monica, Daniele Macor, Omero Alessandro Paoluzi, Giuseppe Scaccianoce, Piero Portincasa, Vincenzo De Francesco, Roberto Lorenzetti, Ilaria Maria Saracino, Matteo Pavoni, Dino Vaira
Publikováno v:
GE: Portuguese Journal of Gastroenterology, Pp 1-6 (2020)
Background: There are no evidence-based recommendations for performing upper gastrointestinal endoscopy (UGIE) in patients with extra-oesophageal symptoms of gastro-oesophageal reflux disease (GORD). However, UGIEs are often performed in clinical pra
Externí odkaz:
https://doaj.org/article/85da55cfe84741019d0be197c1950be0
Autor:
Giammarco Mocci, Antonio Tursi, Giovanni Maconi, Giovanni Cataletti, Beatrice Mantia, Mariaelena Serio, Antonella Scarcelli, Cristiano Pagnini, Maria Giovanna Graziani, Maria Carla Di Paolo, Giuseppe Pranzo, Ileana Luppino, Pietro Paese, Walter Elisei, Rita Monterubbianesi, Roberto Faggiani, Antonio Ferronato, Barbara Perini, Edoardo Savarino, Francesca Maria Onidi, Laura Binaghi, Paolo Usai Satta, Elisa Schiavoni, Daniele Napolitano, Franco Scaldaferri, Daniela Pugliese, Roberta Pica, Andrea Cocco, Maddalena Zippi, Stefano Rodino, Ladislava Sebkova, Giulia Rocco, Carlotta Sacchi, Costantino Zampaletta, Federica Gaiani, Gianluigi De Angelis, Stefano Kayali, Libera Fanigliulo, Roberto Lorenzetti, Leonardo Allegretta, Stefano Scorza, Antonio Cuomo, Laura Donnarumma, Nicola Della Valle, Rodolfo Sacco, Giacomo Forti, Elisabetta Antonelli, Gabrio Bassotti, Chiara Iannelli, Francesco Luzza, Giovanni Aragona, Patrizia Perazzo, Angelo Lauria, Simona Piergallini, Raffaele Colucci, Maria Antonia Bianco, Costantino Meucci, Gianmarco Giorgetti, Valeria Clemente, Serafina Fiorella, Antonio Penna, Antonio De Medici, Marcello Picchio, Alfredo Papa
Publikováno v:
Expert Opinion on Biological Therapy. 23:293-304
Autor:
Bruno Laganà, Angelo Zullo, Maria Lia Scribano, Maria Sole Chimenti, Alberto Migliore, Andrea Picchianti Diamanti, Roberto Lorenzetti, Palma Scolieri, Lorenzo Ridola, Elena Ortona, Marina Pierdominici, Vincenzo Bruzzese
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Spondyloarthritis (SpA) and inflammatory bowel diseases (IBD) are chronic inflammatory diseases characterized by an aberrant immune response and inflammation with a key role for TNF in their pathogenesis. Accordingly, TNF-inhibiting therapy (TNFi) ha
Externí odkaz:
https://doaj.org/article/bcd5e8ab8b6b4bf79c9bf84f3712bbb2
Autor:
Cristiano Pagnini, Andrea Picchianti-Diamanti, Vincenzo Bruzzese, Roberto Lorenzetti, Michele Maria Luchetti, Louis Severino Martin Martin, Roberta Pica, Palma Scolieri, Maria Lia Scribano, Costantino Zampaletta, Maria Sole Chimenti, Bruno Lagana
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 5, p 2456 (2021)
In the last decades, the comprehension of the pathophysiology of bone metabolism and its interconnections with multiple homeostatic processes has been consistently expanded. The branch of osteoimmunology specifically investigating the link between bo
Externí odkaz:
https://doaj.org/article/3b7a245caa2b42c691634a6678b73296
Autor:
Giammarco Mocci, S. Rodinò, Nicola Della Valle, Camilla Graziosi, Tiziana Larussa, Irene Maria Bambina Bergna, Walter Elisei, Giovanni Maconi, Francesco Luzza, Giacomo Forti, Rodolfo Sacco, Roberto Faggiani, Roberto Lorenzetti, Leonardo Allegretta, Marcello Picchio, Giuseppe Pranzo, Antonio Penna, Antonio Ferronato, Raffaele Colucci, Ladislava Sebkova, Costantino Zampaletta, Antonio de Medici, Antonio Tursi
Publikováno v:
Journal of Gastrointestinal and Liver Diseases. 30:456-461
Background and Aims: Several studies have found Golimumab (GOL) effective and safe in the short-term treatment of ulcerative colitis (UC), but few long-term data are currently available from real world. Our aim was to assess the long-term real-life e
Autor:
Costantino Zampaletta, Alessandro Armuzzi, Laura Turchini, Elisa Schiavoni, Daniela Pugliese, Daniele Napolitano, Mariaelena Serio, Antonella Scarcelli, Ladislava Sebkova, Rodolfo Sacco, Stefano Rodino’, Giuseppe Pranzo, Roberta Pica, Patrizia Perazzo, Cristiano Pagnini, Rita Monterubbianesi, Costantino Meucci, Francesco Luzza, Marco Le Grazie, Camilla Graziosi, Laura Donnarumma, Gianluigi De’ Angelis, Andrea Cocco, Valeria Clemente, Stefania Chiri, Alessia Immacolata Cazzato, Gabrio Bassotti, Antonio Penna, Tiziana Larussa, Roberto Lorenzetti, Katia Lofano, Maria Giovanna Graziani, GianMarco Giorgetti, Federica Gaiani, Giacomo Forti, Roberto Faggiani, Nicola Della Valle, Raffaele Colucci, Maria Antonia Bianco, Giovanni Aragona, Leonardo Allegretta, Italian group for switch of biologics, Alfredo Papa, Franco Scaldaferri, Giovanni Maconi, Marcello Picchio, Walter Elisei, Antonio Ferronato, Antonio Cuomo, Giammarco Mocci, Antonio Tursi
Publikováno v:
Journal of gastrointestinal and liver diseases : JGLD. 31(4)
Background and Aims: Adalimumab (ADA) biosimilars have been included into the therapeutic armamentarium of inflammatory bowel disease (IBD); however, comparative data on the efficacy and safety of the different ADA biosimilars after replacing the ADA
Autor:
Giacomo Forti, Raffaele Colucci, Marilisa Franceschi, Walter Elisei, Leonardo Allegretta, GianMarco Giorgetti, S. Rodinò, Giuseppina Grasso, Roberto Lorenzetti, Giammarco Mocci, Roberta Pica, Antonio Penna, Costantino Zampaletta, Francesco Luzza, Tiziana Larussa, Giuseppe Pranzo, Simona Piergallini, Ladislava Sebkova, S. Fiorella, Antonio Ferronato, Roberto Faggiani, Claudio Cassieri, Sarah Porciello, Sara Gallina, Stefano Scorza, Antonio de Medici, Giovanni Brandimarte, Antonio Tursi, Marcello Picchio
Publikováno v:
European Journal of Gastroenterology & Hepatology. 33:670-679
Background Infliximab and adalimumab are widely used for the treatment of Crohn's disease and ulcerative colitis. Aim To compare the long-term efficacy and safety of infliximab and adalimumab in a large cohort of Crohn's disease and ulcerative coliti
Autor:
Antonio Tursi, Giammarco Mocci, Leonardo Allegretta, Giovanni Aragona, Maria Antonia Bianco, Raffaele Colucci, Antonio Cuomo, Nicola Della Valle, Antonio Ferronato, Giacomo Forti, Federica Gaiani, GianMarco Giorgetti, Maria Giovanna Graziani, Katia Lofano, Roberto Lorenzetti, Tiziana Larussa, Antonio Penna, Roberta Pica, Giuseppe Pranzo, Stefano Rodino’, Antonella Scarcelli, Costantino Zampaletta, Gabrio Bassotti, Alessia Immacolata Cazzato, Stefania Chiri, Valeria Clemente, Andrea Cocco, Gianluigi de’ Angelis, Laura Donnarumma, Roberto Faggiani, Camilla Graziosi, Marco Le Grazie, Francesco Luzza, Costantino Meucci, Rita Monterubbianesi, Cristiano Pagnini, Patrizia Perazzo, Marcello Picchio, Rodolfo Sacco, Ladislava Sebkova, Mariaelena Serio, Daniele Napolitano, Daniela Pugliese, Franco Scaldaferri, Elisa Schiavoni, Laura Turchini, Alessandro Armuzzi, Walter Elisei, Giovanni Maconi, Alfredo Papa
Publikováno v:
Inflammatory bowel diseases.
Background Adalimumab (ADA) biosimilars have entered the therapeutic armamentarium of inflammatory bowel disease (IBD), allowing for the treatment of a greater number of patients for their reduced cost than the originator. However, comparative data o